03:12 PM EDT, 06/12/2026 (MT Newswires) -- Healthcare stocks edged lower late Friday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each decreasing 0.2%.

The iShares Biotechnology ETF (IBB) increased 0.1%.

In corporate news, Merck's ( MRK ) Belzutifan in combination with pembrolizumab has been approved for the adjuvant treatment of adults with renal cell carcinoma, the US Food and Drug Administration said Friday. Merck ( MRK ) shares were down 0.8%.